{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:32:26Z","timestamp":1789428746792,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":195,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA200671"],"award-info":[{"award-number":["1R01CA200671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA204345"],"award-info":[{"award-number":["RO1CA204345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["RO1CA235863"],"award-info":[{"award-number":["RO1CA235863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["5P01CA120964"],"award-info":[{"award-number":["5P01CA120964"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["5R35CA197459"],"award-info":[{"award-number":["5R35CA197459"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["5P30CA006516"],"award-info":[{"award-number":["5P30CA006516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["F31CA213460"],"award-info":[{"award-number":["F31CA213460"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ludwig Center at Harvard"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1074\/jbc.ra119.012376","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T15:44:25Z","timestamp":1583423065000},"page":"6263-6277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy"],"prefix":"10.1016","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7812-7675","authenticated-orcid":false,"given":"Renee C.","family":"Geck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson R.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8679-6414","authenticated-orcid":false,"given":"Tracy","family":"Murray Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Asara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Robert A.","family":"Casero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4419","authenticated-orcid":false,"given":"Alex","family":"Toker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.012376_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.012376_bib2","doi-asserted-by":"crossref","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Science Adv"},{"issue":"Suppl. 6","key":"10.1074\/jbc.RA119.012376_bib3","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mds187","article-title":"Triple-negative breast cancer: Epidemiological considerations and recommendations","volume":"23","author":"Boyle","year":"2012","journal-title":"Ann. Oncol"},{"key":"10.1074\/jbc.RA119.012376_bib4","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet"},{"key":"10.1074\/jbc.RA119.012376_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: A review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA119.012376_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/2159-8290.CD-16-0611","article-title":"Adaptive reprogramming of de novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.RA119.012376_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ncb3341","article-title":"Glutathione biosynthesis is a metabolic vulnerability in PI(3)K\/Akt-driven breast cancer","volume":"18","author":"Lien","year":"2016","journal-title":"Nat. Cell Biol"},{"key":"10.1074\/jbc.RA119.012376_bib8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.RA119.012376_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.advms.2018.08.018","article-title":"Metabolic pathways of l-arginine and therapeutic consequences in tumors","volume":"64","author":"Szefel","year":"2019","journal-title":"Adv. Med. Sci"},{"key":"10.1074\/jbc.RA119.012376_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1476-5381.2009.00278.x","article-title":"Recent advances in arginine metabolism: Roles and regulation of the arginases","volume":"157","author":"Morris","year":"2009","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.RA119.012376_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/eji.201546047","article-title":"Induced arginine transport via cationic amino acid transporter-1 is necessary for human T-cell proliferation","volume":"46","author":"Werner","year":"2016","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/jbc.RA119.012376_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/hep.23054","article-title":"Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor","volume":"50","author":"Hoechst","year":"2009","journal-title":"Hepatology"},{"key":"10.1074\/jbc.RA119.012376_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biopha.2018.02.109","article-title":"Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy","volume":"102","author":"Jahani","year":"2018","journal-title":"Biomed. Pharmacother"},{"key":"10.1074\/jbc.RA119.012376_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.04.020","article-title":"Targeting arginine metabolism pathway to treat arginine-dependent cancers","volume":"364","author":"Qiu","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1074\/jbc.RA119.012376_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cncr.20057","article-title":"Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: A method for identifying cancers sensitive to arginine deprivation","volume":"100","author":"Dillon","year":"2004","journal-title":"Cancer"},{"key":"10.1074\/jbc.RA119.012376_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00726-009-0396-7","article-title":"Polyamines: Fundamental characters in chemistry and biology","volume":"38","author":"Agostinelli","year":"2010","journal-title":"Amino Acids"},{"key":"10.1074\/jbc.RA119.012376_bib17","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1042\/BCJ20160383","article-title":"Targeting polyamine metabolism for cancer therapy and prevention","volume":"473","author":"Murray-Stewart","year":"2016","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.RA119.012376_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00726-013-1529-6","article-title":"Polyamine catabolism in carcinogenesis: Potential targets for chemotherapy and chemoprevention","volume":"46","author":"Battaglia","year":"2014","journal-title":"Amino Acids"},{"key":"10.1074\/jbc.RA119.012376_bib19","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/erm.2013.3","article-title":"Polyamines and cancer: Implications for chemotherapy and chemoprevention","volume":"15","author":"Nowotarski","year":"2013","journal-title":"Expert Rev. Mol. Med"},{"key":"10.1074\/jbc.RA119.012376_bib20","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00726-011-1036-6","article-title":"Regulation of polyamine metabolism by translational control","volume":"42","author":"Perez-Leal","year":"2012","journal-title":"Amino Acids"},{"key":"10.1074\/jbc.RA119.012376_bib21","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1074\/jbc.TM118.003337","article-title":"Polyamine catabolism and oxidative damage","volume":"293","author":"Murray Stewart","year":"2018","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012376_bib22","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/jm801580w","article-title":"Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor","volume":"52","author":"Burns","year":"2009","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA119.012376_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/2326-6066.CIR-13-0120-T","article-title":"Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment","volume":"2","author":"Hayes","year":"2014","journal-title":"Cancer Immunol. Res"},{"key":"10.1074\/jbc.RA119.012376_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine metabolism and cancer: Treatments, challenges and opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.RA119.012376_bib25","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA119.012376_bib26","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.3747\/co.25.3954","article-title":"Advances in the systemic treatment of triple-negative breast cancer","volume":"25","author":"Lebert","year":"2018","journal-title":"Curr. Oncol"},{"key":"10.1074\/jbc.RA119.012376_bib27","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: Is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.RA119.012376_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch. Gynecol. Obstet"},{"key":"10.1074\/jbc.RA119.012376_bib29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","article-title":"Efficacy of neoadjuvant cisplatin in triple-negative breast cancer","volume":"28","author":"Silver","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.RA119.012376_bib30","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.celrep.2019.01.059","article-title":"Mapping metabolic events in the cancer cell cycle reveals arginine catabolism in the committed SG2M phase","volume":"26","author":"Roci","year":"2019","journal-title":"Cell Rep"},{"key":"10.1074\/jbc.RA119.012376_bib31","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1074\/jbc.TM118.003336","article-title":"Polyamine synthesis as a target of MYC oncogenes","volume":"293","author":"Bachmann","year":"2018","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012376_bib32","doi-asserted-by":"crossref","first-page":"18730","DOI":"10.1074\/jbc.TM118.003339","article-title":"The antizyme family for regulating polyamines","volume":"293","author":"Kahana","year":"2018","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012376_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1042\/bst0310366","article-title":"Polyamine dependence of normal cell-cycle progression","volume":"31","author":"Oredsson","year":"2003","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.RA119.012376_bib34","first-page":"E65","article-title":"Polyamine biosynthetic pathway as a drug target for osteosarcoma therapy","volume":"6","author":"Weicht","year":"2018","journal-title":"Med. Sci"},{"key":"10.1074\/jbc.RA119.012376_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-017-0014-1","article-title":"Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression","volume":"1","author":"He","year":"2017","journal-title":"NPJ Precis. Oncol"},{"key":"10.1074\/jbc.RA119.012376_bib36","first-page":"915","article-title":"Polyamine starvation prolongs the S and G2 phases of polyamine-dependent (arginase-deficient) CHO cells","volume":"4","author":"Anehus","year":"1984","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.RA119.012376_bib37","first-page":"471","article-title":"Cell-cycle progression and response of germ cell tumors to cisplatin in vitro","volume":"29","author":"Mueller","year":"2006","journal-title":"Int. J. Oncol"},{"key":"10.1074\/jbc.RA119.012376_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/carcin\/23.3.389","article-title":"Flow cytometric analysis of the cell cycle phase specificity of DNA damage induced by radiation, hydrogen peroxide and doxorubicin","volume":"23","author":"Potter","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1074\/jbc.RA119.012376_bib39","first-page":"832","article-title":"Cell cycle-dependent cytotoxicity, G2\/M phase arrest, and disruption of p34cdc2\/cyclin B1 activity induced by doxorubicin in synchronized P388 cells","volume":"49","author":"Ling","year":"1996","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.RA119.012376_bib40","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1158\/2159-8290.CD-12-0305","article-title":"Unbiased metabolite profiling indicates that a diminished thymidine pool is the underlying mechanism of colon cancer chemoprevention by alpha-difluoromethylornithine","volume":"3","author":"Witherspoon","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.RA119.012376_bib41","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/carcin\/22.11.1863","article-title":"Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N\u03c9-hydroxy-l-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines","volume":"22","author":"Singh","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1074\/jbc.RA119.012376_bib42","first-page":"3305","article-title":"Arginase activity in human breast cancer cell lines: N\u03c9-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells","volume":"60","author":"Singh","year":"2000","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.RA119.012376_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1074\/jbc.RA119.012376_bib44","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA119.012376_bib45","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA119.012376_bib46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1158\/1078-0432.CCR-13-0583","article-title":"New strategies for triple-negative breast cancer\u2014deciphering the heterogeneity","volume":"20","author":"Mayer","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.RA119.012376_bib47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1042\/BST0350311","article-title":"Antizyme inhibitor: A defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation","volume":"35","author":"Keren-Paz","year":"2007","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/jbc.RA119.012376_bib48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.012376_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01961162","article-title":"Variations in amplification and expression of the ornithine decarboxylase gene in human breast cancer cells","volume":"19","author":"Thomas","year":"1991","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1074\/jbc.RA119.012376_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ctrv.2017.11.003","article-title":"Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies","volume":"62","author":"Lee","year":"2018","journal-title":"Cancer Treat. Rev"},{"key":"10.1074\/jbc.RA119.012376_bib51","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1074\/jbc.RA119.012376_bib52","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-Myc","volume":"90","author":"Bello-Fernandez","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.012376_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd2243","article-title":"Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases","volume":"6","author":"Casero","year":"2007","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1074\/jbc.RA119.012376_bib54","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1073\/pnas.0906782107","article-title":"The antiapoptotic DeltaNp73 is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway","volume":"107","author":"Dulloo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.012376_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/bm900958c","article-title":"DNA condensation by chiral \u03b1-methylated polyamine analogues and protection of cellular DNA from oxidative damage","volume":"11","author":"Nayvelt","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1074\/jbc.RA119.012376_bib56","doi-asserted-by":"crossref","first-page":"C1204","DOI":"10.1152\/ajpcell.00451.2006","article-title":"Spermidine\/spermine N1-acetyltransferase overexpression in kidney epithelial cells disrupts polyamine homeostasis, leads to DNA damage, and causes G2 arrest","volume":"293","author":"Zahedi","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol"},{"key":"10.1074\/jbc.RA119.012376_bib57","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/dna.2008.0750","article-title":"Polyamine depletion with two different polyamine analogues causes DNA damage in human breast cancer cell lines","volume":"27","author":"Johansson","year":"2008","journal-title":"DNA Cell Biol"},{"key":"10.1074\/jbc.RA119.012376_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ijc.2910380117","article-title":"Radiosensitization of human tumor cells by alpha-difluoromethylornithine","volume":"38","author":"Courdi","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.RA119.012376_bib59","first-page":"47","article-title":"Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine","volume":"46","author":"Seidenfeld","year":"1986","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.RA119.012376_bib60","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/1535-7163.MCT-06-0298","article-title":"Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors","volume":"5","author":"Saunders","year":"2006","journal-title":"Mol. Cancer Ther"},{"key":"10.1074\/jbc.RA119.012376_bib61","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.biocel.2013.02.021","article-title":"Role of polyamines at the G1\/S boundary and G2\/M phase of the cell cycle","volume":"45","author":"Yamashita","year":"2013","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.RA119.012376_bib62","first-page":"3438","article-title":"Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients","volume":"5","author":"O'Shaughnessy","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.RA119.012376_bib63","first-page":"3105","article-title":"A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: Breast tissue, imaging, and serum and urine biomarkers","volume":"8","author":"Fabian","year":"2002","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.RA119.012376_bib64","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1074\/jbc.272.6.3376","article-title":"Interleukin-1-induced growth inhibition of human melanoma cells. Interleukin-1-induced antizyme expression is responsible for ornithine decarboxylase activity down-regulation","volume":"272","author":"Yang","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012376_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1369\/jhc.5A6672.2005","article-title":"Ornithine decarboxylase (ODC) expression pattern in human prostate tissues and ODC transgenic mice","volume":"54","author":"Young","year":"2006","journal-title":"J Histochem. Cytochem"},{"key":"10.1074\/jbc.RA119.012376_bib66","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3748\/wjg.v11.i15.2244","article-title":"Ornithine decarboxylase gene is overexpressed in colorectal carcinoma","volume":"11","author":"Hu","year":"2005","journal-title":"World J. Gastroenterol"},{"key":"10.1074\/jbc.RA119.012376_bib67","first-page":"djz182","article-title":"Association between plasma diacetylspermine and tumor spermine synthase with outcome in triple negative breast cancer","volume":"Sept. 10","author":"Fahrmann","year":"2019","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.RA119.012376_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cels.2017.12.014","article-title":"A landscape of metabolic variation across tumor types","volume":"6","author":"Reznik","year":"2018","journal-title":"Cell Syst"},{"key":"10.1074\/jbc.RA119.012376_bib69","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.RA119.012376_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41596-018-0102-x","article-title":"Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS\/MS","volume":"14","author":"Yuan","year":"2019","journal-title":"Nat. Protoc"},{"key":"10.1074\/jbc.RA119.012376_bib71","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.RA119.012376_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-4347(00)83621-X","article-title":"Solid-phase extraction and determination of dansyl derivatives of unconjugated and acetylated polyamines by reversed-phase liquid chromatography: Improved separation systems for polyamines in cerebrospinal fluid, urine and tissue","volume":"380","author":"Kabra","year":"1986","journal-title":"J. Chromatogr"},{"key":"10.1074\/jbc.RA119.012376_bib73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0076-6879(83)94025-9","article-title":"Ornithine decarboxylase (mouse kidney)","volume":"94","author":"Seely","year":"1983","journal-title":"Methods Enzymol"},{"key":"10.1074\/jbc.RA119.012376_bib74","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2014new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/jbc.RA119.012376_bib75","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00726-012-1413-9","article-title":"Modulation of ethanol effect on hepatocyte proliferation by polyamines","volume":"44","author":"Do","year":"2013","journal-title":"Amino Acids"},{"key":"10.1074\/jbc.RA119.012376_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3835(99)00107-X","article-title":"Quantitative determination of apoptotic death in cultured human pancreatic cancer cells by propidium iodide and digitonin","volume":"142","author":"Zhang","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1074\/jbc.RA119.012376_bib77","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817484936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817484936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.012376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T11:38:15Z","timestamp":1639654695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817484936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":77,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0021925817484936"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.012376","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.08.899492","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.012376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Geck et al.","name":"copyright","label":"Copyright"}]}}